ERBB2 and brain neoplasm: Analysis of the cell surfaceome in pediatric and adult tumors revealed EphA3 as a prominent cell surface protein across various brain tumor subtypes (online supplemental table 1), especially in the context of comparison to existing immunotherapeutic targets in clinical development EphA2, HER2, CD276, CD70, and EGFR (figure 1A).